Who has been buying Pungjeon Pharmaceutical stock?

3 distinct insiders have filed 6 disclosed insider purchases in Pungjeon Pharmaceutical (298060), most recently on 2026-06-30. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Pungjeon Pharmaceutical have?

Pungjeon Pharmaceutical has 6 buy-side and 1 sell-side disclosures on record, covering ₩909M ($631K) in total reported value, spanning 2024-03-31 to 2026-06-30.

Where does StockDrifts get Pungjeon Pharmaceutical insider data?

From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Pungjeon Pharmaceutical 298060

Company

풍전약품Pungjeon Pharmaceutical

Insiders

Buys

Total Value

₩909M ($631K)

Avg Return

-2.49%

Last Filing

2026-06-30

Pungjeon Pharmaceutical (298060) has 6 disclosed insider purchases and 1 disclosed disposals on record, filed by 3 distinct insiders. Together those filings cover ₩909M ($631K) in reported transaction value. The earliest filing StockDrifts holds for Pungjeon Pharmaceutical is dated 2024-03-31; the most recent is 2026-06-30. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -2.49%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2026-06-30	BUY	신규보고	코니 신기술조합 제63호 Kony New Technology Association No. 63	-	429.5K	₩2,825	-4.3%	₩1.2B ($843K)
2026-06-30	BUY	신규보고	코니 신기술조합 제63호 Kony New Technology Association No. 63	-	432.9K	₩2,825	-4.3%	₩1.2B ($849K)
2026-06-30	BUY	제3자배정유상증자	코니 신기술조합 제63호 Kony New Technology Association No. 63	-	796.8K	₩2,825	-4.3%	₩2.3B ($1.6M)
2026-06-09	BUY	Market Buy	김유정 Kim Yu-jeong	CEO	112.7K	₩2,710	-4.1%	₩305M ($212K)
2026-06-08	BUY	Market Buy	김유정 Kim Yu-jeong	CEO	4.6K	₩2,600	+11.2%	₩12M ($8K)
2026-06-05	BUY	Market Buy	김유정 Kim Yu-jeong	CEO	52.6K	₩2,675	+8.0%	₩141M ($98K)
2026-06-04	BUY	Market Buy	김유정 Kim Yu-jeong	CEO	19.0K	₩2,640	+9.5%	₩50M ($35K)
2026-06-02	BUY	Market Buy	김유정 Kim Yu-jeong	CEO	78.4K	₩2,745	+5.3%	₩215M ($149K)
2026-04-24	SELL	주식병합	아리아 신기술조합 제95호 Aria New Technology Association No. 95	-	-3.8M	₩927	+0.0%	₩3.5B ($2.4M)
2026-04-24	SELL	주식병합	마르시아 신기술조합 제77호 Marcia New Technology Association No. 77	-	-9.0M	₩927	+0.0%	₩8.4B ($5.8M)
2026-04-24	SELL	주식병합	유타 신기술조합 제82호 Utah New Technology Association No. 82	-	-3.7M	₩927	+0.0%	₩3.4B ($2.4M)
2025-10-02	BUY	제3자배정유상증자	아리아 신기술조합 제95호 Aria New Technology Association No. 95	-	4.7M	₩1,188	-24.8%	₩5.6B ($3.9M)
2025-08-25	SELL	장외매도	송기령 Song Ki-ryeong	-	-1.2M	₩1,025	+12.8%	₩1.2B ($820K)
2025-07-25	BUY	제3자배정유상증자	유타 신기술조합 제82호 Utah New Technology Association No. 82	-	4.6M	₩1,251	-28.5%	₩5.7B ($4.0M)
2025-07-21	SELL	Market Sell	송기령 Song Ki-ryeong	-	-183.0K	₩1,000	+10.6%	₩183M ($127K)
2025-06-26	BUY	제3자배정유상증자	마르시아 신기술조합 제77호 Marcia New Technology Association No. 77	-	4.0M	₩927	-3.6%	₩3.7B ($2.6M)
2025-03-24	BUY	유상신주취득	마르시아 신기술조합 제77호 Marcia New Technology Association No. 77	-	7.3M	₩1,173	-23.8%	₩8.5B ($5.9M)
2024-10-02	BUY	Market Buy	전명신 Jeon Myeong-shin	Managing Director	1.0K	₩2,125	-57.9%	₩2M ($1K)
2024-06-30	SELL	임원퇴임	이희성 Lee Hee-seong	Outside Director	-8.8K	₩2,720	+67.1%	₩24M ($17K)
2024-03-31	SELL	임원퇴임	손병관 Byeongkwan Son	CEO	-96.2K	₩3,050	+70.7%	₩293M ($204K)

Frequently asked questions

Who has been buying Pungjeon Pharmaceutical stock?: 3 distinct insiders have filed 6 disclosed insider purchases in Pungjeon Pharmaceutical (298060), most recently on 2026-06-30. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Pungjeon Pharmaceutical have?: Pungjeon Pharmaceutical has 6 buy-side and 1 sell-side disclosures on record, covering ₩909M ($631K) in total reported value, spanning 2024-03-31 to 2026-06-30.
Where does StockDrifts get Pungjeon Pharmaceutical insider data?: From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Pungjeon Pharmaceutical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.